Tunisian medtech company Cure Bionics has welcomed a senior delegation of military leaders and officers from the École supérieure de guerre, under the Ministry of National Defence, in a visit that highlights the growing strategic importance of advanced prosthetics, rehabilitation technology and digital health in military healthcare systems.
The delegation, led by Brigadier General Chetoui, visited Cure Bionics’ office in Sousse, where the company presented its work in advanced bionic prosthetics, rehabilitation technologies, artificial intelligence and digital health systems. The visit was shared publicly by Cure Bionics founder Mohamed Dhaouafi, who said the company was proud to support Tunisia’s Ministry of National Defence as a supplier of prosthetic solutions.
For the IMEA region, the visit is significant because it shows how locally developed rehabilitation technologies are increasingly being recognised not only as medical devices, but also as national capability. Military health systems often face complex rehabilitation needs, including traumatic limb loss, high-energy injuries, neurological impairment and long-term reintegration for wounded personnel. In this context, access to reliable prosthetic solutions is part of a broader strategy for recovery, resilience and social participation.
Cure Bionics is based in Sousse, Tunisia, and develops bionic prosthetics for people with limb differences, along with training and therapeutic solutions that use interactive and immersive technologies such as virtual reality and gamification. The company’s listed products and services include the Hannibal Bionic Arm, Angel Cosmetic Arm, Glow Silicon Parts, Hasdrubal Prosthetic Leg, socket manufacturing and rehabilitation services.
The company has positioned itself around accessibility, local production and advanced technology. Its model combines 3D printing, bionic prosthetic design and rehabilitation support, with a focus on making modern prosthetic solutions more available across Africa and the Middle East. A Zero Project 2026 profile describes Cure Bionics as a social start-up pioneering the production and distribution of smart, CE-certified bionic hands in Africa and the Middle East, while also supporting local clinicians through decentralised care.
The military delegation’s visit also reflects a wider shift across the IMEA region. Defence and public health institutions are increasingly looking at prosthetics and rehabilitation technology through a national systems lens. This includes not only the provision of devices, but also training, local manufacturing, digital workflows, follow-up care and long-term rehabilitation outcomes.
For patients with limb loss, especially wounded personnel and people injured during periods of national conflict or instability, prosthetic care is not simply about fitting a device. It requires assessment, socket design, alignment, rehabilitation training, psychological support, maintenance and periodic adjustment. Advanced bionic prostheses may also require user training, software support and structured therapy to achieve functional benefits.
Cure Bionics’ emphasis on artificial intelligence, digital health and immersive rehabilitation tools is therefore important. These technologies can support more personalised prosthetic training, remote follow-up, rehabilitation engagement and user adaptation. Earlier international coverage of Cure Bionics noted the company’s interest in virtual-reality-based training to help users, including children, learn how to operate bionic limbs in a more intuitive and engaging way.
For Tunisia, the company’s role as a supplier to the Ministry of National Defence and the General Directorate of Military Health is notable. Cure Bionics stated that its prosthetic solutions support patients and wounded individuals, including revolution victims. This places the company within a wider rehabilitation mission that connects military medicine, civilian disability services, post-conflict recovery and assistive technology innovation.
The development also carries regional importance for Africa and the Middle East, where access to advanced prosthetic technologies remains uneven. Imported devices can be expensive, maintenance pathways may be difficult, and specialist services are often concentrated in major cities. Locally produced and regionally supported technologies can help reduce some of these barriers, especially when combined with clinician training and service decentralisation.
For the orthotics and prosthetics sector, the visit underlines several important priorities:
Cure Bionics’ engagement with Tunisia’s defence health leadership also demonstrates how innovation in O&P can gain credibility when it addresses real national rehabilitation needs. For governments, the value lies in restoring mobility and independence. For clinicians, the value lies in better tools and service pathways. For users, the value lies in dignity, function and the ability to return to daily life.
As more countries across the IMEA region invest in rehabilitation, assistive technology and digital health, the Cure Bionics visit offers a useful example of how local medtech companies can work with public institutions to strengthen national capacity. The future of prosthetic care in the region will not depend only on imported devices. It will also depend on local innovators, trained clinicians, responsive health systems and partnerships that connect technology with human rehabilitation.